Download PDF
Aktuelle Neurologie 2002; 29(2): 53-62
DOI: 10.1055/s-2002-20537
Neues in der Neurologie
© Georg Thieme Verlag Stuttgart · New York

Grundlagen und klinische Anwendung der MR-Spektroskopie des Gehirns

Basics and Clinical Application of the NMR-Spectroscopy of the BrainP.  Raab1 , U.  Pilatus1 , H.  Lanfermann1 , F.  E.  Zanella1
  • 1Institut für Neuroradiologie, Johann-Wolfgang-Goethe-Universität, Frankfurt/Main
Further Information

Publication History

Publication Date:
04 March 2002 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die MR-Spektroskopie ist zu einem diagnostischen Werkzeug geworden, das vermehrt für die Untersuchung von Krankheitsprozessen des Gehirns genutzt wird. Sie ist ein nichtinvasives Verfahren, mit dessen Hilfe biochemische Veränderungen erfasst und quantifiziert werden können. In dieser Arbeit werden die Entwicklung der Spektroskopie, ihre physikalischen Grundlagen und mögliche Einsatzgebiete in der Neurologie im Rahmen einer Literaturübersicht beschrieben sowie zukünftige Entwicklungen kurz dargestellt.

Abstract

NMR-spectroscopy has become a diagnostic tool which is used for the examination of cerebral pathologies. It is a non-invasive technique, which can detect and quantify biochemical changes. This paper describes the history of NMR-spectroscopy, its technical basis and possible areas of use in Neurology. An overview of the literature is given as well as upcoming developments are mentioned.

Literatur

  • 1 Bloch F, Hansen W, Packard M. The nuclearinduction experiment.  Phys Rev. 1946;  70 474-485
    CrossrefPubMedGoogle Scholar
  • 2 Purcell E, Torrey H, Pound R. Resonance absorption by nuclear magnetic moments in a solid.  Phys Rev. 1946;  69 37-38
    CrossrefPubMedGoogle Scholar
  • 3 Salibi N, Brown M. Clinical MR Spectroscopy: First Principles. New York; Wiley-Liss 1998
    Google Scholar
  • 4 Bottomley P A. Spatial localization in NMR spectroscopy in vivo.  Ann N Y Acad Sci. 1987;  508 333-348
    CrossrefPubMedGoogle Scholar
  • 5 Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging.  Phys Med Biol. 1985;  30 341-344
    CrossrefPubMedGoogle Scholar
  • 6 Provencher S W. Automatic quantitation of localized in vivo (1)H spectra with LCModel.  NMR Biomed. 2001;  14 260-264
    CrossrefPubMedGoogle Scholar
  • 7 Bluml S. In vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T.  J Magn Reson. 1999;  136 219-225
    CrossrefPubMedGoogle Scholar
  • 8 Constantinidis I. MRS methodology.  Adv Neurol. 2000;  83 235-246
    PubMedGoogle Scholar
  • 9 Michaelis T, Merboldt K, Hänicke W. et al . On the identification of cerebral metabolites in localized 1H NMR spectra of human brain in vivo.  NMR Biomed. 1991;  4 90-98
    CrossrefPubMedGoogle Scholar
  • 10 Pouwels P J, Brockmann K, Kruse B. et al . Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS (in Process Citation).  Pediatr Res. 1999;  46 474-485
    CrossrefPubMedGoogle Scholar
  • 11 Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy.  Magn Reson Q. 1994;  10 191-247
    PubMedGoogle Scholar
  • 12 Kreis R, Ernst T, Ross B D. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy.  Magn Reson Med. 1993;  30 424-437
    CrossrefPubMedGoogle Scholar
  • 13 Gill S S, Thomas D G, van Bruggen N. et al . Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies.  J Comput Assist Tomogr. 1990;  14 497-504
    PubMedGoogle Scholar
  • 14 Shino A, Nakasu S, Matsuda M. et al . Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.  J Neurosurg. 1999;  91 928-934
    PubMedGoogle Scholar
  • 15 Brulatout S, Meric P, Loubinoux I. et al . A one-dimensional (proton and phosphorus) and two-dimensional (proton) in vivo NMR spectroscopic study of reversible global cerebral ischemia.  J Neurochem. 1996;  66 2491-2499
    PubMedGoogle Scholar
  • 16 Higuchi T, Graham S H, Fernandez E J. et al . Effects of severe global ischemia on N-acetylaspartate and other metabolites in the rat brain.  Magn Reson Med. 1997;  37 851-857
    PubMedGoogle Scholar
  • 17 Pouwels P J, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.  Magn Reson Med. 1998;  39 53-60
    PubMedGoogle Scholar
  • 18 Govindaraju V, Young K, Maudsley A A. Proton NMR chemical shifts and coupling constants for brain metabolites.  NMR Biomed. 2000;  13 129-153
    CrossrefPubMedGoogle Scholar
  • 19 Tsai G, Coyle J T. N-acetylaspartate in neuropsychiatric disorders.  Prog Neurobiol. 1995;  46 531-540
    CrossrefPubMedGoogle Scholar
  • 20 de Stefano N, Matthews P M, Arnold D L. Reversible decreases in N-acetylaspartate after acute brain injury.  Magn Reson Med. 1995;  34 721-727
    CrossrefPubMedGoogle Scholar
  • 21 Wittsack H J, Kugel H, Roth B, Heindel W. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease.  J Magn Reson Imaging. 1996;  6 889-893
    PubMedGoogle Scholar
  • 22 Chamuleau R A, Bosman D K, Bovee W M. et al . What the clinician can learn from MR glutamine/glutamate assays.  NMR Biomed. 1991;  4 103-108
    PubMedGoogle Scholar
  • 23 Pan J W, Lane J B, Hetherington H, Percy A K. Rett syndrome: 1H spectroscopic imaging at 4.1 Tesla.  J Child Neurol. 1999;  14 524-528
    PubMedGoogle Scholar
  • 24 Chang L, Ernst T, Osborn D. et al . Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats.  Arch Neurol. 1998;  55 305-311
    CrossrefPubMedGoogle Scholar
  • 25 Bluml S, Zuckerman E, Tan J, Ross B D. Proton-decoupled 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy.  J Neurochem. 1998;  71 1564-1576
    PubMedGoogle Scholar
  • 26 Ross B D. Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites.  NMR Biomed. 1991;  4 59-63
    CrossrefPubMedGoogle Scholar
  • 27 Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.  Dev Neurosci. 1993;  15 289-298
    PubMedGoogle Scholar
  • 28 Shonk T K, Moats R A, Gifford P. et al . Probable Alzheimer disease: diagnosis with proton MR spectroscopy.  Radiology. 1995;  195 65-72
    PubMedGoogle Scholar
  • 29 Moats R A, Ernst T, Shonk T K, Ross B D. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease.  Magn Reson Med. 1994;  32 110-115
    PubMedGoogle Scholar
  • 30 Ross B D, Ernst T, Kreis R. et al . 1H MRS in acute traumatic brain injury.  J Magn Reson Imaging. 1998;  8 829-840
    CrossrefPubMedGoogle Scholar
  • 31 Bonavita S, di Salle F, Tedeschi G. Proton MRS in neurological disorders.  Eur J Radiol. 1999;  30 125-131
    CrossrefPubMedGoogle Scholar
  • 32 Kawaguchi S, Kamada K, Itamoto K. et al . Proton MR spectroscopy in patients with unilateral temporal lobe epilepsy.  No To Shinkei. 1995;  47 43-48
    PubMedGoogle Scholar
  • 33 So E L. Classifications and epidemiologic considerations of epileptic seizures and epilepsy.  Neuroimaging Clin N Am. 1995;  5 513-526
    PubMedGoogle Scholar
  • 34 Cendes F, Andermann F, Dubeau F, Arnold D L. Proton magnetic resonance spectroscopic images and MRI volumetric studies for lateralization of temporal lobe epilepsy.  Magn Reson Imaging. 1995;  13 1187-1191
    PubMedGoogle Scholar
  • 35 Gadian D G. N-acetylaspartate and epilepsy.  Magn Reson Imaging. 1995;  13 1193-1195
    PubMedGoogle Scholar
  • 36 Stefan H, Eberhardt K E, Pauli E. et al . Diagnostic imaging in refractory temporal lobe epilepsy. A comparison of MR volumetry and multivoxel-MR-spectroscopy for assessment of postoperative prognosis.  Nervenarzt. 2001;  72 130-135
    CrossrefPubMedGoogle Scholar
  • 37 Hsu Y Y, Chang C, Chang C N. et al . Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging.  AJNR. 1999;  20 643-651
    PubMedGoogle Scholar
  • 38 Ende G R, Laxer K D, Knowlton R C. et al . Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging.  Radiology. 1997;  202 809-817
    PubMedGoogle Scholar
  • 39 Mendes-Ribeiro J A, Soares R, Simoes-Ribeiro F, Guimaraes M L. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?.  J Neurol Neurosurg Psychiatry. 1998;  65 518-522
    PubMedGoogle Scholar
  • 40 Pioro E P. MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease.  J Neurol Sci. 1997;  152, Suppl 1 S49-53
    CrossrefPubMedGoogle Scholar
  • 41 Bradley W G, Bowen B C, Pattany P M, Rotta F. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis.  J Neurol Sci. 1999;  169 84-86
    CrossrefPubMedGoogle Scholar
  • 42 Kenn W, Ochs G, Pabst T A, Hahn D. 1H spectroscopy in patients with amyotrophic lateral sclerosis.  J Neuroimaging. 2001;  11 293-297
    PubMedGoogle Scholar
  • 43 Barker P B, Lee R R, McArthur J C. AIDS dementia complex: evaluation with proton MR spectroscopic imaging.  Radiology. 1995;  195 58-64
    PubMedGoogle Scholar
  • 44 Laubenberger J, Haussinger D, Bayer S. et al . HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times.  Radiology. 1996;  199 805-810
    PubMedGoogle Scholar
  • 45 Chang L, Ernst T, Leonido-Yee M. et al . Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia.  Neurology. 1999;  53 782-789
    CrossrefPubMedGoogle Scholar
  • 46 Henriksen O. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS.  NMR Biomed. 1995;  8 139-148
    CrossrefPubMedGoogle Scholar
  • 47 Arnold D L, de Stefano N, Narayanan S, Matthews P M. Proton MR spectroscopy in multiple sclerosis.  Neuroimaging Clin N Am. 2000;  10 789-798
    PubMedGoogle Scholar
  • 48 Fu L, Matthews P M, de Stefano N. et al . Imaging axonal damage of normal-appearing white matter in multiple sclerosis.  Brain. 1998;  121 103-113
    CrossrefPubMedGoogle Scholar
  • 49 Miller D H, Albert P S, Barkhof F. et al . Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.  Ann Neurol. 1996;  39 6-16
    CrossrefPubMedGoogle Scholar
  • 50 Baslow M H. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease.  J Mol Neurosci. 2000;  15 61-69
    CrossrefPubMedGoogle Scholar
  • 51 Berger J, Moser H W, Forss-Petter S. Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment.  Curr Opin Neurol. 2001;  14 305-312
    CrossrefPubMedGoogle Scholar
  • 52 Tzika A A, Ball W S, Vigneron D B. et al . Childhood adrenoleukodystrophy: assessment with proton MR spectroscopy.  Radiology. 1993;  189 467-480
    PubMedGoogle Scholar
  • 53 Pouwels P J, Kruse B, Korenke G C. et al . Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy.  Neuropediatrics. 1998;  29 254-264
    PubMedGoogle Scholar
  • 54 Matthews P M, Tampieri D, Berkovic S F. et al . Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome.  Neurology. 1991;  41 1043-1046
    PubMedGoogle Scholar
  • 55 Matthews P M, Andermann F, Silver K. et al . Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies.  Neurology. 1993;  43 2484-2490
    PubMedGoogle Scholar
  • 56 Lanfermann H, Kugel H, Heindel W. et al . Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging.  Radiology. 1995;  196 203-210
    PubMedGoogle Scholar
  • 57 Giroud M, Walker P, Guy F. et al . Cerebral metabolism after transient ischemic attack. A 1H MR spectroscopy study.  Neurol Res. 1999;  21 563-565
    PubMedGoogle Scholar
  • 58 Barker P B, Gillard J H, van Zijl P C. et al . Acute stroke: evaluation with serial proton MR spectroscopic imaging.  Radiology. 1994;  192 723-732
    PubMedGoogle Scholar
  • 59 Gillard J H, Barker P B, van Zijl P C. et al . Proton MR spectroscopy in acute middle cerebral artery stroke.  AJNR. 1996;  17 873-886
    PubMedGoogle Scholar
  • 60 Ernst T, Chang L, Melchor R, Mehringer C M. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.  Radiology. 1997;  203 829-836
    PubMedGoogle Scholar
  • 61 Kattapong V J, Brooks W M, Wesley M H. et al . Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia.  Arch Neurol. 1996;  53 678-680
    PubMedGoogle Scholar
  • 62 Herminghaus S, Gorriz C, Pilatus U. et al .Vascular dementia: improved diagnosis using Proton NMR Spectroscopy. In 1st International Congress on Vascular Dementia. Bologna; Int Proc Division 1998
    Google Scholar
  • 63 Herminghaus S, Gorriz C, Pilatus U. et al .Vascular dementia: non invasive assay of pathologic neurochemistry using proton NMR spectroscopy. In 1st International Congress on Vascular Dementia. Bologna; Int Proc Division 1998
    Google Scholar
  • 64 Bruhn H, Michaelis T, Merboldt K D. et al . On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro.  NMR Biomed. 1992;  5 253-258
    PubMedGoogle Scholar
  • 65 Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study.  Neurosurgery. 1994;  35 606-613
    PubMedGoogle Scholar
  • 66 Sutton L N, Wehrli S L, Gennarelli L. et al . High-resolution 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro.  J Neurosurg. 1994;  81 443-448
    PubMedGoogle Scholar
  • 67 Usenius J P, Vainio P, Hernesniemi J, Kauppinen R A. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro.  J Neurochem. 1994;  63 1538-1543
    PubMedGoogle Scholar
  • 68 Carpinelli G, Carapella C M, Palombi L. et al . Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors.  Anticancer Res. 1996;  16 1559-1563
    PubMedGoogle Scholar
  • 69 Gray H F, Maxwell R J, Martinez-Perez I. et al . Genetic programming for classification and feature selection: analysis of 1H nuclear magnetic resonance spectra from human brain tumour biopsies.  NMR Biomed. 1998;  11 217-224
    CrossrefPubMedGoogle Scholar
  • 70 Tzika A A, Vigneron D B, Ball W S. et al . Localized proton MR spectroscopy of the brain in children.  J Magn Reson Imaging. 1993;  3 719-729
    PubMedGoogle Scholar
  • 71 Chang L, Miller B L, McBride D. et al . Brain lesions in patients with AIDS: H-1 MR spectroscopy.  Radiology. 1995;  197 525-531
    PubMedGoogle Scholar
  • 72 Go K G, Kamman R L, Mooyaart E L. et al . Localized proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.  Neuroradiology. 1995;  37 198-206
    PubMedGoogle Scholar
  • 73 Falini A, Calabrese G, Origgi D. et al . Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives.  J Neurol. 1996;  243 706-714
    PubMedGoogle Scholar
  • 74 Negendank W G, Sauter R, Brown T R. et al . Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.  J Neurosurg. 1996;  84 449-458
    CrossrefPubMedGoogle Scholar
  • 75 Thomas M A, Ryner L N, Mehta M P. et al . Localized 2D J-resolved 1H MR spectroscopy of human brain tumors in vivo.  J Magn Reson Imaging. 1996;  6 453-459
    PubMedGoogle Scholar
  • 76 de Stefano N, Caramanos Z, Preul M C. et al . In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.  Ann Neurol. 1998;  44 273-278
    CrossrefPubMedGoogle Scholar
  • 77 Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.  NMR Biomed. 1997;  10 2-12
    CrossrefPubMedGoogle Scholar
  • 78 Choi C G, Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times.  Magn Reson Med. 1999;  41 204-207
    CrossrefPubMedGoogle Scholar
  • 79 Poptani H, Gupta R K, Roy R. et al . Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.  AJNR. 1995;  16 1593-1603
    PubMedGoogle Scholar
  • 80 Preul M C, Caramanos Z, Collins D L. et al . Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.  Nat Med. 1996;  2 323-325
    PubMedGoogle Scholar
  • 81 Shimizu H, Kumabe T, Tominaga T. et al . Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.  AJNR. 1996;  17 737-747
    PubMedGoogle Scholar
  • 82 Arle J E, Morriss C, Wang Z J. et al . Prediction of posterior fossa tumor type in children by means of magnetic resonance image properties, spectroscopy, and neural networks.  J Neurosurg. 1997;  86 755-761
    PubMedGoogle Scholar
  • 83 Tzika A A, Vajapeyam S, Barnes P D. Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations.  AJNR. 1997;  18 203-218
    PubMedGoogle Scholar
  • 84 Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy.  Radiology. 1993;  186 745-752
    PubMedGoogle Scholar
  • 85 Demaerel P, Johannik K, van Hecke P. et al . Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors.  J Comput Assist Tomogr. 1991;  15 67-76
    PubMedGoogle Scholar
  • 86 Sijens P E, Knopp M V, Brunetti A. et al . 1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study.  Magn Reson Med. 1995;  33 818-826
    PubMedGoogle Scholar
  • 87 Henriksen O. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS.  NMR Biomed. 1995;  8 139-148
    CrossrefPubMedGoogle Scholar
  • 88 Miller B L. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline.  NMR Biomed. 1991;  4 47-52
    PubMedGoogle Scholar
  • 89 de Certaines J, Larsen V, Podo F. et al . In vivo 31P MRS of experimental tumours.  NMR Biomed. 1993;  6 345-365
    PubMedGoogle Scholar
  • 90 Lowry O H, Berger S J, Chi M M. et al . Diversity of metabolic patterns in human brain tumors - I. High energy phosphate compounds and basic composition.  J Neurochem. 1977;  29 959-977
    PubMedGoogle Scholar
  • 91 Nadler J V, Cooper J R. N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues.  J Neurochem. 1972;  19 313-319
    PubMedGoogle Scholar
  • 92 Shimizu H, Kumabe T, Shirane R, Yoshimoto T. Correlation between Choline Level Measured by Proton MR Spectroscopy and Ki-67 Labeling Index in Gliomas.  AJNR. 2000;  21 659-665
    PubMedGoogle Scholar
  • 93 Tamiya T, Kinoshita K, Ono Y. et al . Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas.  Neuroradiology. 2000;  42 333-338
    CrossrefPubMedGoogle Scholar
  • 94 Burtscher I M, Skagerberg G, Geijer B. et al . Proton MR Spectroscopy and Preoperative Diagnostic Accuracy: An Evaluation of Intracranial Mass Lesions Characterized by Stereotactic Biopsy Findings.  AJNR. 2000;  21 84-374
    PubMedGoogle Scholar
  • 95 Sijens P E, Levendag P C, Vecht C J. et al . 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors.  NMR Biomed. 1996;  9 65-71
    CrossrefPubMedGoogle Scholar
  • 96 Lehnhardt F G, Rohn G, Ernestus R I. et al . 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components.  NMR Biomed. 2001;  14 307-317
    CrossrefPubMedGoogle Scholar
  • 97 Castillo M, Kwock L. Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors.  Top Magn Reson Imaging. 1999;  10 104-113
    CrossrefPubMedGoogle Scholar
  • 98 Harada M, Tanouchi M, Miyoshi H. et al . Brain abscess observed by localized proton magnetic resonance spectroscopy.  Magn Reson Imaging. 1994;  12 1269-1274
    CrossrefPubMedGoogle Scholar
  • 99 Poptani H, Gupta R K, Jain V K. et al . Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis.  Magn Reson Imaging. 1995;  13 1019-1029
    PubMedGoogle Scholar
  • 100 Cecil K M, Lenkinski R E. Proton MR spectroscopy in inflammatory and infectious brain disorders.  Neuroimaging Clin N Am. 1998;  8 863-880
    PubMedGoogle Scholar
  • 101 Burtscher I M, Holtas S. In vivo proton MR spectroscopy of untreated and treated brain abscesses.  AJNR. 1999;  20 1049-1053
    PubMedGoogle Scholar

Dr. med. Peter Raab

Institut für Neuroradiologie, Johann-Wolfgang-Goethe-Universität

Schleusenweg 2 - 16

60528 Frankfurt

      >